October 28, 2019
Since 2015 we have acted for OPAL Rheumatology Limited, a public NFP company that provides statistical analytical services to a majority of the multinational suppliers of prescription rheumatology pharmaceuticals. Our work has included assisting in contracts with critical service providers […]
October 28, 2019
During the period 2004-2017 we acted as lead external counsel to CSL Limited (ASX:CSL) and its subsidiary Seqirus Pty Ltd (aka CSL Biotherapies Pty Ltd) on contractual arrangements with the Commonwealth of Australia for the supply of seasonal influenza vaccine […]
October 28, 2019
Having acted as external counsel on commercial and IP matters for Spinifex Pharmaceuticals from 2008, through a number of capital raises (including its 2014 re-domestication to USA). We also acted as lead local counsel alongside Goodwin Proctor (US) in the […]
October 11, 2019
We first acted for Dr Elaine Saunders and Professor Peter Blamey, founders of Dynamic Hearing, nearly twenty years ago. Recently we assisted them navigate growth, external investment and conclude a successful exit of their second company, BlameySaundersHears.